These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 15688042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J, Koochesfahani KM, Zaharik ML, Shen C, Brunham RC.
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.
    Su H, Morrison R, Messer R, Whitmire W, Hughes S, Caldwell HD.
    J Infect Dis; 1999 Oct; 180(4):1252-8. PubMed ID: 10479155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM.
    Vaccine; 2006 Feb 06; 24(6):766-75. PubMed ID: 16199110
    [Abstract] [Full Text] [Related]

  • 10. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection.
    Gray RT, Beagley KW, Timms P, Wilson DP.
    J Infect Dis; 2009 Jun 01; 199(11):1680-8. PubMed ID: 19432550
    [Abstract] [Full Text] [Related]

  • 11. Immune-mediated control of Chlamydia infection.
    Roan NR, Starnbach MN.
    Cell Microbiol; 2008 Jan 01; 10(1):9-19. PubMed ID: 17979983
    [Abstract] [Full Text] [Related]

  • 12. The immunology of Chlamydia trachomatis.
    Zdrodowska-Stefanow B, Ostaszewska-Puchalska I, Puciło K.
    Arch Immunol Ther Exp (Warsz); 2003 Jan 01; 51(5):289-94. PubMed ID: 14626428
    [Abstract] [Full Text] [Related]

  • 13. HtrA, RseP, and Tsp proteins do not elicit a pathology-related serum IgG response during sexually transmitted infection with Chlamydia trachomatis.
    Huston WM, Armitage CW, Lawrence A, Gloeckl S, Bell SJ, Debattista J, Allan JA, Timms P, Queensland Clinical Chlamydia Research Network.
    J Reprod Immunol; 2010 Jun 01; 85(2):168-71. PubMed ID: 20444505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
    Rey-Ladino J, Ross AG, Cripps AW.
    Hum Vaccin Immunother; 2014 Jun 01; 10(9):2664-73. PubMed ID: 25483666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L, Ifere GO, He Q, Igietseme JU, Kellar KL, Okenu DM, Eko FO.
    FEMS Immunol Med Microbiol; 2007 Feb 01; 49(1):46-55. PubMed ID: 17094789
    [Abstract] [Full Text] [Related]

  • 18. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI.
    J Microbiol Immunol Infect; 2005 Dec 01; 38(6):383-93. PubMed ID: 16341338
    [Abstract] [Full Text] [Related]

  • 19. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
    Pal S, Peterson EM, de la Maza LM.
    Vaccine; 2005 Nov 16; 23(46-47):5351-8. PubMed ID: 16085340
    [Abstract] [Full Text] [Related]

  • 20. Considerations for the rational design of a Chlamydia vaccine.
    Liang S, Bulir D, Kaushic C, Mahony J.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):831-835. PubMed ID: 27835064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.